Half of substance users have recently been victims of crime
Nov. 16, 2017 1:18 PM
Victimization was associated with symptoms of poor mental health, more serious substance use and unstable housing.
Extended-release naltrexone as effective as buprenorphine-naloxone on retention in treatment and reducing use of heroin and other Illicit opioids in head-to-head comparison trial
Oct. 20, 2017 11:57 AM
In the 12-week, open-label, randomized-controlled study, 159 patients with opioid dependence were randomized to treatment with either extended-release naltrexone or buprenorphine-naloxone, following detoxification.
Abstinent networks contribute to increased quality of life
Oct. 5, 2017 9:58 AM
A new article from the NorComt study at SERAF examine how patients are doing one year after starting in treatment and investigate the impact of abstinent networks.